Bioinformatics Breakthroughs in Gastric Cancer Research: Identifying New Biomarkers and Therapeutic Targets

Strategic Insights -

Recent research from Guilan University of Medical Sciences in Rasht, Iran, has made significant strides in understanding gastric cancer through the application of bioinformatics. Gastric cancer, one of the most prevalent malignancies globally, has a high mortality rate due to its molecular heterogeneity, late-stage diagnosis, and limited efficacy of existing therapies. The study aimed to investigate the fluctuations and performance of MYD88 and GRB2 gene expression in gastric cancer, identifying them as potential diagnostic biomarkers.

Key Takeaways:

  • The research focused on the bioinformatics analysis of two significant genes, GRB2 and MYD88, associated with gastric cancer progression and immune response regulation.
  • Analyzing data from public databases, the study found that elevated GRB2 expression correlates significantly with tumor invasion, making it a potential independent prognostic marker and therapeutic target in gastric cancer.
  • The expression of MYD88 is associated with the activation of the NF-kB signaling pathway, induced by Helicobacter pylori infection, contributing to chronic inflammation and tumorigenesis.
  • Functional enrichment analysis revealed that both genes are involved in essential oncogenic pathways, such as cell proliferation, immune response regulation, and inflammatory signaling.
  • The study highlights the importance of GRB2 and MYD88 in gastric cancer progression and proposes them as therapeutic targets to enhance patient outcomes.
  • Authors Seyed Mustafa Mirnezami, Saman Morovat, Afshin Shafaghi, Seyedeh Elham Norollahi, Kourosh Delpasand, Kosar Babaei, Ali Ashraf, and Ali Akbar Samadani contributed to this research.

Statistics:

  • Gastric cancer ranks as the fourth most prevalent malignancy and constitutes the second leading cause of cancer-related mortality globally.
  • The mortality rate among gastric cancer patients is elevated due to molecular heterogeneity, late-stage diagnosis, and limited efficacy of existing therapies.
  • The study analyzed data from public databases such as GEPIA2, TIMER, GeneMANIA, and Cytoscape.
  • Elevated GRB2 expression correlates with tumor invasion in gastric cancer, and its expression is significantly higher in gastric cancer tissues compared to normal tissues.
  • The NF-kB signaling pathway is activated by Helicobacter pylori infection, contributing to chronic inflammation and tumorigenesis.

Sources:

  • [1] Bioinformatic-based study to investigate the fluctuations and performance of MYD88 and GRB2 gene expression in gastric cancer; Can they be considered diagnostic biomarkers?.

Cancer Treatment and Research Communications, 2025, 45():101006.

Publisher: Elsevier

DOI: 10.1016/j.ctarc.2025.101006

Free version available at: https://doi-org.sdpl.idm.oclc.org/10.1016/j.ctarc.2025.101006

Contact: Seyed Mustafa Mirnezami, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran